Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Demographic, Clinical, and Para Clinical Features in Patients With Covid-19 and St-Elevation Myocardial Infarction; [ویژگیهای دموگرافیک، کلینیکی و پاراکلینیکی در بیماران مبتال به انفارکتوس میوکارد با صعود قطعهی St و بیماری کووید- 91] Publisher



Shemirani H1 ; Imani H2 ; Nematollahi A3 ; Babak A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Resident of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Community of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2023


Abstract

Background: The aims of this study were to determine the prognosis in heart infarction patients who were also suffering from COVID-19 disease and its relationship with underlying diseases and blood factors and the severity of pulmonary involvement. Methods: This cross-sectional descriptive study extracted data from the medical records of patients hospitalized in Alzahra, Chamran, and Khorsheed hospitals in Isfahan city from 2020 to 2021. Individuals over 18 years old diagnosed with myocardial infarction and positive polymerase chain reaction (PCR) test placed under angiography were included in the study. Variables studied included age, gender, comorbidities, medications, smoking history, vaccination status, laboratory findings, echocardiography, angiography, and mortality. Logistic regression analysis was used to analyze the data. Findings: A total of 65 patients were examined. The most common comorbidity was hypertension (55.4%) and the most common symptom was chest pain (84.6%). Left ventricular ejection fraction decreased (38.2%), and this decrease was significant in patients with ST-elevation myocardial infarction (33.5% vs. 43.7%, P = 0.0009). Thrombosis was observed in 14 patients, which was more common in the ST-elevation myocardial infarction (STEMI) group than in the non-ST-elevation myocardial infarction (NSTEMI) group (30.8% vs. 7.7%, P = 0.03). The most involved artery was LAD (60%). There was no significant association between the severity of COVID-19 and myocardial infarction subtypes. Moreover, these subgroups did not show a significant association with mortality rates. Conclusion: No significant association was found between the severity of COVID-19 and myocardial infarction subtypes in our study. © 2023 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Other Related Docs
11. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
36. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
37. Immune System Changes During Covid-19 Recovery Play Key Role in Determining Disease Severity, International Journal of Immunopathology and Pharmacology (2020)
39. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
43. Is Lp(A), As Predictor of Severity of Coronary Artery Disease?, Journal of Isfahan Medical School (2009)